Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study
Janice Austin, Frances C Wright, Stephanie Y Cheng, Rinku Sutradhar, Nancy N Baxter, Nicole J Look Hong
Annals of Surgical Oncology | SPRINGER | Published : 2020
INTRODUCTION: Few studies have examined outcomes in immunosuppressed patients who develop melanoma. The purpose of this study is to compare survival in immunosuppressed patients who developed melanoma with that in patients with melanoma who are not immunosuppressed. METHODS: Immunosuppressed patients were defined as having solid organ transplant, lymphoma, leukemia, or human immunodeficiency virus prior to diagnosis of melanoma. Patients with cutaneous melanoma with and without immunosuppression were identified retrospectively from the Ontario Cancer Registry (2007-2015) and linked with administrative databases to identify demographics, treatment, and outcomes. Immunosuppressed patients were..View full abstract
Academic Enrichment Fund for General Surgery at Sunnybrook Health Sciences Centre. Mahaffy Research Grant.